iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Hits New 52-Week High – Still a Buy?

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)’s share price reached a new 52-week high on Wednesday . The stock traded as high as $92.42 and last traded at $92.42, with a volume of 11949 shares trading hands. The stock had previously closed at $91.19.

iShares U.S. Pharmaceuticals ETF Stock Performance

The stock has a market cap of $992.09 million, a price-to-earnings ratio of 17.75 and a beta of 0.49. The company’s 50 day simple moving average is $87.26 and its two-hundred day simple moving average is $86.44.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the stock. Hudock Inc. increased its stake in iShares U.S. Pharmaceuticals ETF by 3.9% in the 4th quarter. Hudock Inc. now owns 3,034 shares of the company’s stock valued at $257,000 after buying an additional 114 shares during the period. Sunbelt Securities Inc. increased its stake in iShares U.S. Pharmaceuticals ETF by 14.3% in the 1st quarter. Sunbelt Securities Inc. now owns 960 shares of the company’s stock valued at $83,000 after buying an additional 120 shares during the period. O Shaughnessy Asset Management LLC increased its stake in iShares U.S. Pharmaceuticals ETF by 35.0% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 463 shares of the company’s stock valued at $39,000 after buying an additional 120 shares during the period. National Bank of Canada FI increased its stake in iShares U.S. Pharmaceuticals ETF by 42.7% in the 3rd quarter. National Bank of Canada FI now owns 585 shares of the company’s stock valued at $42,000 after buying an additional 175 shares during the period. Finally, Root Financial Partners LLC increased its stake in shares of iShares U.S. Pharmaceuticals ETF by 36.5% during the 1st quarter. Root Financial Partners LLC now owns 696 shares of the company’s stock worth $60,000 after purchasing an additional 186 shares during the last quarter.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.